Skip to main content
SpringerLink
Log in

Clinical and histological resolution of invasive squamous cell carcinoma by topical imiquimod 3.75%: a case report

  • Correspondence
  • Published:
European Journal of Dermatology

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Stratigos A, Garbe C, Lebbe C, et al. Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline. Eur J Cancer 2015; 51: 1989–2007.

    Article  PubMed  Google Scholar 

  2. Tiodorovic-Zivkovic D, Zalaudek I, Longo C, De Pace B, Albertini G, Argenziano G. Successful treatment of two invasive squamous cell carcinomas with topical 5% imiquimod cream in elderly patients. Eur J Dermatol 2012; 22: 579–80.

    PubMed  Google Scholar 

  3. Peris K, Micantonio T, Fargnoli MC, Lozzi GP, Chimenti S. Imiquimod 5% cream in the treatment of Bowen’s disease and invasive squamous cell carcinoma. J Am Acad Dermatol 2006; 55: 324–7.

    Article  PubMed  Google Scholar 

  4. Gaspari AA. Mechanism of action and other potential roles of an immune response modifier. Cutis 2007; 79: 36–45.

    PubMed  Google Scholar 

  5. Schon M, Bong AB, Drewniok C, et al. Tumor-selective induction of apoptosis and the small-molecule immune response modifier imiquimod. J Natl Cancer Inst 2003; 95: 1138–49.

    Article  PubMed  Google Scholar 

  6. Stockfleth E, Gupta G, Peris K, Aractingi S, Dakovic R, Alomar A. Reduction in lesions from Lmax: a new concept for assessing efficacy of field-directed therapy for actinic keratosis. Results with imiquimod 3. 75%. Eur J Dermatol 2014; 24: 23–7.

    CAS  PubMed  Google Scholar 

  7. Gupta G, Stockfleth E, Peris K, et al. Long-term sustained lesion clearance from Lmax with imiquimod 3.75%, a new fielddirected treatment for actinic keratosis. J Eur Acad Dermatol Venereol 2015; 29: 1840–2.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dermatological Practice Centre, Wuppertal, Germany

    Thomas Dirschka, Lutz Schmitz & Ágota Bartha

  2. Faculty of Health, University Witten-Herdecke, Herdecke, Germany

    Thomas Dirschka

  3. Department of Dermatology, Ruhr-University, Bochum, Germany

    Lutz Schmitz

Authors
  1. Thomas Dirschka
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lutz Schmitz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ágota Bartha
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Thomas Dirschka.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dirschka, T., Schmitz, L. & Bartha, Á. Clinical and histological resolution of invasive squamous cell carcinoma by topical imiquimod 3.75%: a case report. Eur J Dermatol 26, 408–409 (2016). https://doi.org/10.1684/ejd.2016.2788

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1684/ejd.2016.2788

Search

Navigation